| dc.description.abstract | Corporate Social Responsibility (CSR) has become an essential aspect of the business
strategy for pharmaceutical companies worldwide, including in Bangladesh. This study
examines the CSR practices of three leading pharmaceuticals Companies: Square
Pharmaceuticals Ltd., Beximco Pharmaceuticals Ltd., and ACI Pharmaceuticals Ltd. to
understand their contributions to healthcare, social development, and environmental
sustainability. The research employs a combination of case studies, secondary data
analysis, and stakeholder insights to evaluate the impact and challenges of CSR initiatives
in the pharmaceutical sector.
Findings reveal that these companies have significantly contributed to improving
healthcare access, promoting education, and adopting sustainable practices. Their CSR
efforts have enhanced their corporate reputation, customer loyalty, and business
performance, demonstrating a strong alignment between social responsibility and
commercial success. However, the study identifies challenges in measuring the long-term
impact and sustaining these initiatives amid evolving societal and regulatory demands.
The research also highlights emerging trends, such as the integration of innovation and
technology in CSR, and increasing stakeholder expectations, which will shape the future
of CSR in the pharmaceutical industry.
This study offers recommendations for policymakers and companies to enhance CSR
practices, emphasizing transparency, collaboration, and sustainable development. It
provides valuable insights into how CSR can drive positive change in society while
ensuring the sustainable growth of the pharmaceutical industry in Bangladesh | en_US |
